| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-46 |
Sentence |
denotes |
25-Hydroxyvitamin D transport in human plasma. |
| T2 |
47-117 |
Sentence |
denotes |
Isolation and partial characterization of calcifidiol-binding protein. |
| T3 |
118-250 |
Sentence |
denotes |
The binding protein for 25-hydroxycholecalciferol (25-OH-D3 or calcifidiol) in human plasma has been purified from Cohn Fraction IV. |
| T4 |
251-490 |
Sentence |
denotes |
Following in vitro labeling with 25-OH-[3H]D3, the isolation sequence of procedures included: DEAE-cellulose chromatography; gel filtration on Sephadex G-200; chromatography on DEAE-Sephadex; preparative polyacrylamide gel electrophoresis. |
| T5 |
491-672 |
Sentence |
denotes |
These procedures resulted in a calcifidiol-binding protein (Cal-BP) which had been purified approximately 170-fold, and which was homogeneous by physical and immunological criteria. |
| T6 |
673-811 |
Sentence |
denotes |
The purified Cal-BP had inter-alpha mobility, a sedimentation constant (S20, w) of 3.46 S, and a molecular weight of approximately 59,000. |
| T7 |
812-1037 |
Sentence |
denotes |
Sucrose gradient ultracentrifugation of Cal-BP and ligand incubations indicated that there was apparently one binding site for either cholecalciferol, calcifidiol or 1,25-dihydroxycholecalciferol per molecule of human Cal-BP. |
| T8 |
1038-1172 |
Sentence |
denotes |
The protein had highest affinity for calcifidiol, displaying an apparent dissociation constant (Kd) of 6.4 X 10(-8) M for this sterol. |
| T9 |
1173-1309 |
Sentence |
denotes |
Specific anti-human Cal-BP antisera were prepared in rabbits, and produced precipitate lines of identity between Cal-BP and human serum. |
| T10 |
1310-1580 |
Sentence |
denotes |
Specific binding of vitamin D3,25-OH-D3, and 1,25-(OH)2D3 by human serum was completely neutralized after immunoprecipitation of the serum with the gamma globulin fraction of anti-Cal-BP antiserum, indicating a common transport protein for these sterols in human plasma. |
| T11 |
1581-1752 |
Sentence |
denotes |
There was no immunological cross-reactivity between Cal-BP and rat or chicken sera, indicating that the Cal-BP in these three sera are immunologically completely distinct. |
| T12 |
1753-1926 |
Sentence |
denotes |
Purified human Cal-BP and human sera also produced lines of identity with commercial anti-human group-specific component (Gc) antisera in radial immunodiffusion experiments. |
| T13 |
1927-2069 |
Sentence |
denotes |
This finding supports an earlier report of the identity of calciferol/calcifidiol-binding protein and group-specific component in human serum. |
| T14 |
2070-2189 |
Sentence |
denotes |
The Cal-BP content of human serum is approximately 10(-5) M, whereas the calcifidiol content is approximately 10(-7) M. |
| T15 |
2190-2261 |
Sentence |
denotes |
Normally, the dominant moiety of human plasma Cal-BP is the apoprotein. |
| T1 |
0-46 |
Sentence |
denotes |
25-Hydroxyvitamin D transport in human plasma. |
| T2 |
47-117 |
Sentence |
denotes |
Isolation and partial characterization of calcifidiol-binding protein. |
| T3 |
118-250 |
Sentence |
denotes |
The binding protein for 25-hydroxycholecalciferol (25-OH-D3 or calcifidiol) in human plasma has been purified from Cohn Fraction IV. |
| T4 |
251-490 |
Sentence |
denotes |
Following in vitro labeling with 25-OH-[3H]D3, the isolation sequence of procedures included: DEAE-cellulose chromatography; gel filtration on Sephadex G-200; chromatography on DEAE-Sephadex; preparative polyacrylamide gel electrophoresis. |
| T5 |
491-672 |
Sentence |
denotes |
These procedures resulted in a calcifidiol-binding protein (Cal-BP) which had been purified approximately 170-fold, and which was homogeneous by physical and immunological criteria. |
| T6 |
673-811 |
Sentence |
denotes |
The purified Cal-BP had inter-alpha mobility, a sedimentation constant (S20, w) of 3.46 S, and a molecular weight of approximately 59,000. |
| T7 |
812-1037 |
Sentence |
denotes |
Sucrose gradient ultracentrifugation of Cal-BP and ligand incubations indicated that there was apparently one binding site for either cholecalciferol, calcifidiol or 1,25-dihydroxycholecalciferol per molecule of human Cal-BP. |
| T8 |
1038-1172 |
Sentence |
denotes |
The protein had highest affinity for calcifidiol, displaying an apparent dissociation constant (Kd) of 6.4 X 10(-8) M for this sterol. |
| T9 |
1173-1309 |
Sentence |
denotes |
Specific anti-human Cal-BP antisera were prepared in rabbits, and produced precipitate lines of identity between Cal-BP and human serum. |
| T10 |
1310-1580 |
Sentence |
denotes |
Specific binding of vitamin D3,25-OH-D3, and 1,25-(OH)2D3 by human serum was completely neutralized after immunoprecipitation of the serum with the gamma globulin fraction of anti-Cal-BP antiserum, indicating a common transport protein for these sterols in human plasma. |
| T11 |
1581-1752 |
Sentence |
denotes |
There was no immunological cross-reactivity between Cal-BP and rat or chicken sera, indicating that the Cal-BP in these three sera are immunologically completely distinct. |
| T12 |
1753-1926 |
Sentence |
denotes |
Purified human Cal-BP and human sera also produced lines of identity with commercial anti-human group-specific component (Gc) antisera in radial immunodiffusion experiments. |
| T13 |
1927-2069 |
Sentence |
denotes |
This finding supports an earlier report of the identity of calciferol/calcifidiol-binding protein and group-specific component in human serum. |
| T14 |
2070-2189 |
Sentence |
denotes |
The Cal-BP content of human serum is approximately 10(-5) M, whereas the calcifidiol content is approximately 10(-7) M. |
| T15 |
2190-2261 |
Sentence |
denotes |
Normally, the dominant moiety of human plasma Cal-BP is the apoprotein. |